V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270013481 | 270014247 | null | 62.4 | Curative (C) | 2014-05-25 | 2014-05-25 | HD EuroNet-PHL-C1 OEPA | 2 | N | 270014973 | OEPA |
| 270013482 | 270009075 | 1.75 | 98.999 | Curative (C) | 2014-10-05 | 2014-11-01 | Cisplatin + Radiotherapy | N | Y | 270014975 | CISPLATIN + RT |
| 270013483 | 270009076 | 1.65 | 102 | null | 2014-03-03 | 2014-03-08 | Rituximab | N | N | 270014976 | RITUXIMAB |
| 270013484 | 270009077 | 1.77 | 79.8 | Palliative (P) | 2017-03-13 | 2017-06-07 | Cetuximab + FOLFIRI cycle1 | 2 | null | 270014979 | CETUXIMAB + IRINOTECAN + MDG |
| 270013485 | 270014251 | 1.72 | 57.2 | Curative (C) | 2014-09-16 | 2014-10-17 | LEAM | 02 | N | 270014981 | LEAM |
| 270013486 | 270009081 | 1.43 | 103.9 | Palliative (P) | 2013-09-19 | 2013-09-19 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | Y | 270014984 | CETUXIMAB + IRINOTECAN + MDG |
| 270013487 | 270009085 | 1.57 | 61.3 | Curative (C) | null | 2016-08-03 | OEPA | 2 | N | 270014985 | OEPA |
| 270013488 | 270009087 | 1.89 | 56.1 | Curative (C) | 2018-01-12 | 2018-01-15 | BEAM | null | null | 270014987 | BEAM |
| 270013489 | 270009087 | 1.88 | null | Curative (C) | 2016-06-30 | 2016-07-01 | CISPLATIN + RT | N | Y | 270014987 | CISPLATIN + RT |
| 270013490 | 270009087 | 1.92 | 94 | Curative (C) | 2017-01-21 | 2017-02-19 | Cisplatin + Radiotherapy | N | N | 270014987 | CISPLATIN + RT |
| 270013491 | 270009088 | 1.62 | 84.2 | Curative (C) | 2016-01-08 | 2016-01-16 | Rituximab | N | Y | 270014996 | RITUXIMAB |
| 270013492 | 270009088 | 1.59 | null | Curative (C) | 2017-02-02 | 2017-02-02 | ESHAP | N | N | 270014996 | ESHAP |
| 270013493 | 270009093 | 1.76 | 66 | null | 2016-05-16 | 2016-05-16 | Rituximab | 01 | N | 270014999 | RITUXIMAB |
| 270013494 | 270009095 | 1.7 | 76.299 | Curative (C) | 2016-06-19 | 2016-07-01 | HD EuroNet-PHL-C1 OEPA | N | N | 270015003 | OEPA |
| 270013495 | 270009096 | null | null | Curative (C) | 2015-07-15 | 2015-07-15 | ESHAP | null | null | 270015004 | ESHAP |
| 270013496 | 270009099 | 0 | 48.98 | Curative (C) | 2015-10-27 | 2015-10-28 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015007 | CETUXIMAB + IRINOTECAN + MDG |
| 270013497 | 270009100 | 1.78 | 17 | Curative (C) | 2013-02-27 | 2013-02-27 | LEAM | N | N | 270015010 | LEAM |
| 270013498 | 270009101 | 1.28 | 96.1 | Curative (C) | null | 2015-04-09 | ESHAP | N | N | 270015011 | ESHAP |
| 270013499 | 270009103 | 1.56 | 55 | Disease modification (D) | 2016-11-22 | 2016-11-23 | Rituximab | 2 | N | 270015014 | RITUXIMAB |
| 270013500 | 270009103 | null | null | Curative (C) | 2015-07-19 | 2015-07-19 | Rituximab | N | N | 270015014 | RITUXIMAB |
| 270013501 | 270009106 | 1.64 | 95.7 | Curative (C) | null | 2017-02-24 | ESHAP | N | N | 270015017 | ESHAP |
| 270013502 | 270009106 | 1.82 | 103 | Curative (C) | 2017-10-05 | 2017-10-05 | ESHAP | N | Y | 270015017 | ESHAP |
| 270013503 | 270014263 | 1.78 | 97 | Palliative (P) | 2015-03-03 | 2015-03-04 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015020 | CETUXIMAB + IRINOTECAN + MDG |
| 270013504 | 270009108 | 1.66 | 65 | Curative (C) | 2013-05-12 | 2013-05-14 | Rituximab | 01 | N | 270015029 | RITUXIMAB |
| 270013505 | 270009109 | 1.72 | 67.6 | Curative (C) | 2017-11-01 | 2018-01-07 | BEAM | N | N | 270015030 | BEAM |
| 270013506 | 270009110 | 1.66 | 46.6 | Curative (C) | 2015-05-01 | 2015-05-01 | BEAM | N | null | 270015033 | BEAM |
| 270013507 | 270009111 | 1.85 | 72.2 | Curative (C) | 2013-05-02 | 2013-05-03 | LEAM | 2 | Y | 270015034 | LEAM |
| 270013508 | 270009111 | 1.8 | 87 | Curative (C) | null | 2018-06-12 | ESHAP | N | N | 270015034 | ESHAP |
| 270013509 | 270009111 | 1.8 | 55.4 | null | 2014-11-17 | 2014-11-30 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270015034 | CISPLATIN + RT |
| 270013510 | 270009111 | 1.69 | 33.3 | Curative (C) | 2017-06-10 | 2017-06-19 | BEAM | N | N | 270015034 | BEAM |
| 270013511 | 270009111 | 1.72 | 69.3 | Curative (C) | 2017-05-02 | 2017-05-04 | ESHAP | N | N | 270015034 | ESHAP |
| 270013512 | 270009112 | 1.8 | 56.4 | Curative (C) | 2013-09-12 | 2013-09-17 | OEPA | N | N | 270015043 | OEPA |
| 270013513 | 270009113 | 1.8 | 77 | Curative (C) | 2017-05-26 | 2017-05-29 | Mini BEAM | N | null | 270015047 | BEAM |
| 270013514 | 270009113 | 1.98 | 85.8 | Palliative (P) | null | 2017-05-27 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270015047 | CETUXIMAB + IRINOTECAN + MDG |
| 270013515 | 270009117 | 1.78 | 124 | Curative (C) | 2013-05-28 | 2013-06-20 | LEAM | 2 | N | 270015050 | LEAM |
| 270013516 | 270009117 | null | 58.2 | Curative (C) | 2017-12-14 | 2017-12-20 | BEAM | N | N | 270015050 | BEAM |
| 270013517 | 270009118 | 0 | 55.8 | Curative (C) | 2018-04-16 | 2018-04-16 | Rituximab | 2 | N | 270015054 | RITUXIMAB |
| 270013518 | 270009120 | 1.75 | 69.3 | Palliative (P) | 2014-08-13 | 2014-09-03 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270015061 | CETUXIMAB + IRINOTECAN + MDG |
| 270013519 | 270009120 | 1.6 | 85 | Curative (C) | 2014-06-30 | 2014-07-15 | OEPA | null | null | 270015061 | OEPA |
| 270013520 | 270009122 | 1.76 | 87.35 | null | 2014-04-18 | 2014-12-01 | LEAM | 2 | N | 270015062 | LEAM |
| 270013521 | 270016829 | 1.72 | 77.1 | Curative (C) | 2014-05-20 | 2014-06-01 | BEAM | N | N | 270015065 | BEAM |
| 270013522 | 270016829 | 0 | 56.1 | Curative (C) | 2014-03-28 | 2014-03-28 | LEAM | N | N | 270015065 | LEAM |
| 270013523 | 270016829 | 1.73 | 80 | Curative (C) | 2015-05-01 | 2015-05-29 | LEAM | N | N | 270015065 | LEAM |
| 270013524 | 270009125 | 1.88 | 52.2 | Disease modification (D) | 2015-08-05 | 2015-08-05 | BEAM | N | N | 270015072 | BEAM |
| 270013525 | 270009126 | 1.7 | 87 | Palliative (P) | 2014-04-04 | 2014-05-01 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 270015075 | CETUXIMAB + IRINOTECAN + MDG |
| 270013526 | 270009129 | 1.63 | 54.6 | Curative (C) | null | 2015-12-15 | OEPA | N | N | 270015077 | OEPA |
| 270013527 | 270009130 | 1.71 | 52 | Curative (C) | 2016-02-14 | 2016-03-04 | ESHAP | N | N | 270015080 | ESHAP |
| 270013528 | 270009131 | 1.86 | 74.8 | Adjuvant (A) | null | 2014-01-20 | OEPA | N | N | 270015083 | OEPA |
| 270013529 | 270009132 | null | 48.9 | Curative (C) | 2016-04-14 | 2016-05-13 | Rituximab | N | null | 270015089 | RITUXIMAB |
| 270013530 | 270009133 | 1.8 | 55 | Curative (C) | 2013-03-30 | 2013-03-31 | OEPA | N | N | 270015090 | OEPA |